share_log

CVS Health | 8-K: Current report

CVS Health | 8-K: Current report

西維斯健康 | 8-K：重大事件
美股SEC公告 ·  05/09 16:27
Moomoo AI 已提取核心訊息
On May 9, 2024, CVS Health Corporation successfully issued and sold a series of Senior Notes totaling $5 billion. The offering included 5.400% Senior Notes due 2029, 5.550% Senior Notes due 2031, 5.700% Senior Notes due 2034, 6.000% Senior Notes due 2044, and 6.050% Senior Notes due 2054. This debt issuance was made under the company's Registration Statement on Form S-3ASR, initially filed on May 25, 2023. The Senior Notes are part of a broader agreement governed by a Senior Indenture dated August 15, 2006, between CVS Health and The Bank of New York Mellon Trust Company, N.A., as trustee. The company retains the option to issue additional senior debt securities under this agreement. The forms of the newly issued Notes have been filed with the SEC and are incorporated by reference into the Registration Statement.
On May 9, 2024, CVS Health Corporation successfully issued and sold a series of Senior Notes totaling $5 billion. The offering included 5.400% Senior Notes due 2029, 5.550% Senior Notes due 2031, 5.700% Senior Notes due 2034, 6.000% Senior Notes due 2044, and 6.050% Senior Notes due 2054. This debt issuance was made under the company's Registration Statement on Form S-3ASR, initially filed on May 25, 2023. The Senior Notes are part of a broader agreement governed by a Senior Indenture dated August 15, 2006, between CVS Health and The Bank of New York Mellon Trust Company, N.A., as trustee. The company retains the option to issue additional senior debt securities under this agreement. The forms of the newly issued Notes have been filed with the SEC and are incorporated by reference into the Registration Statement.
2024年5月9日，CVS Health Corporation成功發行並出售了一系列總額爲50億美元的優先票據。此次發行包括2029年到期的5.400％的優先票據、2031年到期的5.550％的優先票據、2034年到期的5.700％的優先票據、2044年到期的6.000％的優先票據和2054年到期的6.050％的優先票據。本次債務發行是根據該公司最初於 2023 年 5 月 25 日提交的 S-3ASR 表格註冊聲明進行的。優先票據是CVS Health與作爲受託人的紐約銀行梅隆信託公司於2006年8月15日簽訂的優先契約管理的更廣泛協議的一部分。根據本協議，公司保留髮行額外優先債務證券的選擇權。新發行的票據的表格已向美國證券交易委員會提交，並以引用方式納入註冊聲明。
2024年5月9日，CVS Health Corporation成功發行並出售了一系列總額爲50億美元的優先票據。此次發行包括2029年到期的5.400％的優先票據、2031年到期的5.550％的優先票據、2034年到期的5.700％的優先票據、2044年到期的6.000％的優先票據和2054年到期的6.050％的優先票據。本次債務發行是根據該公司最初於 2023 年 5 月 25 日提交的 S-3ASR 表格註冊聲明進行的。優先票據是CVS Health與作爲受託人的紐約銀行梅隆信託公司於2006年8月15日簽訂的優先契約管理的更廣泛協議的一部分。根據本協議，公司保留髮行額外優先債務證券的選擇權。新發行的票據的表格已向美國證券交易委員會提交，並以引用方式納入註冊聲明。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息